Get the Stockscreener App
131.37
3.55%
4.78
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $131.37, with a volume of 1.30M.
It is up +3.55% in the last 24 hours and up +16.47% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$126.59
Open:
$125.94
24h Volume:
1.30M
Relative Volume:
0.87
Market Cap:
$14.65B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
62.27
EPS:
2.1097
Net Cash Flow:
$492.62M
1W Performance:
+3.75%
1M Performance:
+16.47%
6M Performance:
+37.13%
1Y Performance:
+49.18%
1-Day Range:
$125.94
$131.75
1-Week Range:
$125.46
$131.75
52-Week Range:
$81.22
$131.75
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
131.33 | 13.85B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
608.83 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
210.30 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
325.64 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
264.45 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
151.24 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity stock trades around $123 as investors weigh latest earnings and analyst targets - Ad-hoc-news.de
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Revvity (RVTY) Stock Is Up Today - Quiver Quantitative
Revvity stock hits new 52-week high as gains extend - Ad-hoc-news.de
Revvity stock hits 52-week high at 122.26 USD - Investing.com
Revvity stock hits 52-week high at 122.26 USD By Investing.com - Investing.com India
Revvity Inc (RVTY) Shares Surge 5.0% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Revvity stock edges lower as SuperFlex launch and Q2 earnings shape valuation debate - Ad-hoc-news.de
Revvity Inc (RVTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity (NYSE: RVTY) executive gifts 27,785 shares to trust - Stock Titan
Revvity (NYSE:RVTY) Gains Attention After SuperFlex Launch - Kalkine Media
Revvity CEO Prahlad Singh Transfers Over 67,000 Shares to Family Trusts in Gift Transactions - Kalkine Media
Revvity (NYSE: RVTY) CEO shifts stock into family trusts at $0 - Stock Titan
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with Modest Upside and Resilient Performance - DirectorsTalk Interviews
Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold" - MarketBeat
T. Rowe Price (RVTY) reports 16.4% Revvity stake, 18.3M shares under control - Stock Titan
T. Rowe Price Associates (RVTY) discloses 5.0% beneficial stake in Revvity - Stock Titan
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs - Zacks Investment Research
Revvity (NYSE:RVTY) Hits New 12-Month HighWhat's Next? - MarketBeat
Revvyty Inc stock hits 52-week high at 118.34 USD By Investing.com - Investing.com South Africa
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
Taylor Farms Recall Puts Food Safety Stocks On Retail Investors Radar - sahmcapital.com
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - Stock Titan
Revvity (RVTY) Q2 2026 Earnings Call Transcript - aol.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Revvity, Inc. (RVTY) stock price, news, quote and history - Yahoo Finance UK
Revvity Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia Testing - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovation With A 5.59% Upside - DirectorsTalk Interviews
Bank of America Corp DE Increases Stake in Revvity Inc. $RVTY - MarketBeat
Revvity Q2 Earnings Call Highlights - Yahoo Finance
Will Raised 2026 Revenue Guidance and Diagnostics Strength Change Revvity's (RVTY) Narrative - webull.com
Revvity (NYSE:RVTY) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Revvity, Inc. (RVTY) Stock forecasts - Yahoo Finance UK
Revvity, Inc. (0KHE) Q3 2022 Earnings ReportResults, Call & Slides - tipranks.com
REVVITY, INC. : STIFEL RAISES TARGET PRICE TO $110 FROM $100 - webull.com
Revvity (NYSE:RVTY) Rating Increased to Hold at Zacks Research - marketbeat.com
Arrowstreet Capital Limited Partnership Sells 328,169 Shares of Revvity Inc. $RVTY - MarketBeat
Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY? - Yahoo Finance
Stifel raises Revvity stock price target to $110 on earnings beat - Investing.com
REVVITY, INC. : JP MORGAN RAISES TARGET PRICE TO $110 FROM $90 - Moomoo
Revvity posts solid Q2 2026 earnings growth - The Globe and Mail
Amundi Sells 32,858 Shares of Revvity Inc. $RVTY - MarketBeat
Revvity, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):